Health Bulletin 25/August/2022

Published On 2022-08-25 12:30 GMT   |   Update On 2023-10-20 06:20 GMT
Advertisement

Here are the top health news for the day:

Tomato Flu not related to SARS-CoV-2, monkeypox, dengue, chikungunya, Centre sent advisory to states

With the rising cases of Tomato flu in the country, the Centre has sent an advisory to states on Tomato Flu, also known as tomato fever.

According to an advisory, the infection, which appears to be a type of Hand, Foot, and Mouth Disease (HFMD), primarily affects children under the age of 10, though it can also affect adults.

Advertisement

Medical colleges cannot admit beyond sanctioned limit or MBBS admission deadline: Madras HC

In a recent judgment, the Madras High Court bench has held that the MBBS admissions need to be commensurate with the annual intake capacity of the concerned medical college.

Reiterating the earlier orders of the Supreme Court directing to strictly follow the schedule for admission, the Madras HC bench comprising of Justice Abdul Quddhose recently dismissed a plea by MBBS aspirants who sought admission under the wards of defence personnel quota and noted, "...it is clear that neither intake of students can be allowed beyond the sanctioned limit nor time schedule for completion of the admissions for the medical colleges can be extended...The regulations streamlining the admission of students in medical college are made to maintain higher standards in medical education."

For more details, check out the link given below:

Medical colleges cannot admit beyond sanctioned limit or MBBS admission deadline: Madras HC


Drug safety alert: IPC flags adverse reactions linked to cephalosporin antibiotic cefoperazone

 The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of August, has revealed that a broad-spectrum cephalosporin antibiotic Cefoperazone is linked with Adverse Drug Reactions (ADRs) named Coagulopathy, a condition in which the blood's ability to coagulate (form clots) is impaired..

This came after preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India (PvPI) database.

For more details, check out the link given below:

Drug safety alert: IPC flags adverse reactions linked to cephalosporin antibiotic cefoperazone


GMC Keonjhar gets NMC letter of intent for 100 MBBS seats

Another 100 MBBS seats are going to be added to the seat matrix of Odisha since the National Medical Commission (NMC) has issued the Letter of Intent (LOI) to the new Government Medical College in Keonjhar district for commencing admissions in 100 MBBS seats from the 2022-2023 academic session.

Issuing the LOI, the Medical Assessment and Rating Board (MARB) of the Commission has directed the State Government for submit an undertaking with an assurance to provide all the facilities as per the NMC norms.

For more details, check out the link given below:

GMC keonjhar gets NMC letter of intent for 100 MBBS seats


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News